Abstracts

978 – Catastrophic Healthcare Expenditure From Cryptococcal Meningitis in Eastern and Southern Africa

Background HIV-associated cryptococcal meningitis is the second leading cause of AIDS-related mortality. Cryptococcal meningitis is a poverty-related disease and the majority of cases occur in settings where resources are limited and access to quality care is often linked to an individual’s ability to pay for services. We have previously demonstrated the efficacy, safety, and cost-effectiveness…

973 – Uptake of New Guidelines for Cryptococcal Meningitis in Botswana, Malawi, Uganda, and Zimbabwe

Background WHO guidelines for HIV-associated cryptococcal meningitis were updated in June 2022 recommending single, high-dose liposomal amphotericin with 14 days of flucytosine and fluconazole. The AMBITION team who defined that regimen lead the Single High-dose AmBisome to Reduce Mortality from CM (SHARE-CM) project aiming to maximise the impact of the regimen in routine care. The…

957 – Isoniazid Exposure Among Patients With Tuberculosis and Diabetes in Brazil

Background We previously demonstrated that individuals with tuberculosis (TB) and uncontrolled diabetes mellitus (DM) had a lower risk of TB-treatment related adverse drug reactions. Hypothesizing that this could be related to low TB drug levels, we correlated isoniazid (INH) plasma concentrations with glycated hemoglobin (HbA1c) levels Methods We included culture-confirmed, drug-susceptible, pulmonary TB participants from the RePORT-Brazil cohort, who received standard TB…

989 – Characteristics and Outcomes of Pregnant Women With HIV Undergoing Tuberculosis Screening in Uganda

Background Systematic screening for tuberculosis (TB) may be particularly important for pregnant women with HIV (PWWH), as pregnancy increases TB risk independent of HIV. However, little is known about PWWH undergoing TB screening. We describe characteristics and pregnancy outcomes of PWWH enrolled in an ongoing trial evaluating the impact of two WHO-approved TB screening strategies…

964 – Evaluating the Accuracy of Standard F TB-Feron FIA for TB Infection Diagnosis in Vietnam

Background In Vietnam, national guidelines require a Tuberculosis (TB) infection test before TB preventive therapy can be administered. However, Interferon Gamma Release Assays (IGRAs) require advanced laboratories for processing, resulting in limited access. The Standard F TB-Feron fluorescent immunoassay (TB-Feron) is a simplified IGRA which requires less manual handling and no specialized laboratory staff. Methods This cross-sectional…

961 – Machine Learning-Based Prediction of Active Tuberculosis in People With HIV Using Clinical Data

Background Coinfections of Mycobacterium tuberculosis (MTB) and human immunodeficiency virus (HIV) represent a significant global health challenge. Patients infected with MTB are at elevated risk of progressing to active tuberculosis (TB), a risk that can be mitigated by preventive therapy. However, current testing methods frequently fail to identify individuals who will later develop active TB,…

907 – Noncommunicable Diseases: A Significant Cause of Death Among People Living With HIV in Nigeria

Background Antiretroviral therapy (ART) has significantly reduced AIDS-related deaths, yet death rates remain higher among people living with HIV (PLHIV) compared with individuals without HIV. This has been partly attributed to a higher risk of non-communicable diseases (NCDs) among PLHIV. Providing insights into NCDs’ contribution to the cause of death among PLHIV will guide priority…

844 – PLHIV Exhibit a COVID-19 Independent Increase of Cardiovascular Mortality in Brazil, 2019-2023

Background Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among PLHIV. The COVID-19 pandemic exacerbated existing health disparities, particularly affecting vulnerable populations. This study aims to investigate the impact of the COVID-19 pandemic on death rates due to CVD in Brazil. Methods All data were sourced from Brazilian Mortality Information System (SIM)…